News

General newsMedia releasesResearchClinical research & trials

Peter Mac Researchers and Clinicians elected Fellows of the AAHMS

October 10, 2019
Peter Mac’s Professor Monica Slavin, Professor Karin Thursky, Professor Gail Risbridger and Associate Professor Prue Francis have been elected as Fellows of the Australian Academy of Health and Medical Sciences.
Read more
A/Prof Alicia Oshlack
General newsResearch

New co-Head of Computational Biology Program appointed

October 1, 2019
Internationally-recognised bioinformatics expert, A/Prof Alicia Oshlack, will join the Peter Mac Research team following her recent appointment as co-Head of the Computational Biology Program.
Read more
Media releasesResearch

Tassie Devils hold clue for how human cancers evade the immune system

September 27, 2019
Melbourne researchers from Peter Mac, in collaboration with Cancer Research UK, have uncovered a new way that some human cancers can hide from the body’s immune system, a feature they share with tumours from an unlikely source - the Tasmanian devil.
Read more
General newsMedia releases

Welcoming our new Chief Executive Dr Shelley Dolan

September 23, 2019
Today we welcome Dr Shelley Dolan to Peter Mac and to Australia.
Read more
Featured servicesConferences & seminars

BOOK NOW: GAP 2020

September 20, 2019
Peter Mac is proud to host the MD Anderson Cancer Center Global Academic Program (GAP) 2020 conference for the first time in Australia.
Read more
Featured services

Oncology Massage Service

September 17, 2019
Peter Mac patients are able to book an Oncology Massage on Wednesdays and Fridays. (Currently suspended)
Read more
Dr Kylie Gorringe
General newsClinical research & trials

Rare ovarian cancer confirmed as not seeded from elsewhere

September 6, 2019
An international study led by Peter Mac has revealed the origin of mucinous ovarian cancer (MOC) confirming, unlike other types of ovarian cancer, this rare cancer is not seeded from elsewhere in the body.
Read more
General news

Milestone as Australia’s first T-Cell therapy manufacturing license is awarded

August 29, 2019
Peter MacCallum Cancer Centre welcomes the issuing of the first license to manufacture commercial T-Cell treatments, including breakthrough CAR T-Cell therapies, within Australia. The Therapeutic Goods Administration has awarded a T-Cells GMP manufacturing licence to Cell Therapies Pty Ltd, a company which is situated at Peter Mac.
Read more
Professor Ricky Johnstone, Executive Director of Cancer Research at Peter Mac.
General newsResearchClinical research & trials

Success for Peter Mac research in latest NHMRC grant round

August 29, 2019
Groundbreaking research projects led by Peter Mac scientists and clinician researchers have attracted more than $19 million in the latest round of NHMRC grants. The funded projects include a major study of the role of vasculature in cancer progression, research into improved infection control in cancer patients, and improving the effectiveness of immunotherapies and personalised cancer treatments.
Read more
General newsMedia releasesClinical research & trials

Positive results from first-in-class, first-in-human trial of blood cancer drug

August 21, 2019
Peter Mac scientists working with the drug company Senhwa Biosciences have developed a new way to target cancer, and have demonstrated it can stall disease progression in patients who are no longer responding to conventional treatments.
Read more